- Home
- JANX vs HIMX Comparison
JANX vs HIMX Comparison
Compare JANX & HIMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- HIMX
- Stock Information
- Founded
- JANX 2017
- HIMX 2001
- Country
- JANX United States
- HIMX Taiwan
- Employees
- JANX N/A
- HIMX N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- HIMX Semiconductors
- Sector
- JANX Health Care
- HIMX Technology
- Exchange
- JANX Nasdaq
- HIMX Nasdaq
- Market Cap
- JANX 1.4B
- HIMX 1.5B
- IPO Year
- JANX 2021
- HIMX 2006
- Fundamental
- Price
- JANX $23.15
- HIMX $8.67
- Analyst Decision
- JANX Strong Buy
- HIMX Buy
- Analyst Count
- JANX 11
- HIMX 1
- Target Price
- JANX $76.55
- HIMX $15.00
- AVG Volume (30 Days)
- JANX 714.6K
- HIMX 948.2K
- Earning Date
- JANX 11-05-2025
- HIMX 11-06-2025
- Dividend Yield
- JANX N/A
- HIMX 4.33%
- EPS Growth
- JANX N/A
- HIMX N/A
- EPS
- JANX N/A
- HIMX 0.42
- Revenue
- JANX $439,000.00
- HIMX $889,561,000.00
- Revenue This Year
- JANX N/A
- HIMX N/A
- Revenue Next Year
- JANX $130.50
- HIMX $16.64
- P/E Ratio
- JANX N/A
- HIMX $20.12
- Revenue Growth
- JANX N/A
- HIMX N/A
- 52 Week Low
- JANX $21.73
- HIMX $5.12
- 52 Week High
- JANX $71.71
- HIMX $13.91
- Technical
- Relative Strength Index (RSI)
- JANX 48.91
- HIMX 55.80
- Support Level
- JANX $21.73
- HIMX $8.47
- Resistance Level
- JANX $24.54
- HIMX $9.01
- Average True Range (ATR)
- JANX 1.07
- HIMX 0.27
- MACD
- JANX -0.06
- HIMX 0.03
- Stochastic Oscillator
- JANX 47.38
- HIMX 64.20
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About HIMX Himax Technologies Inc.
Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.